Comparative Efficacy of Cangrelor in Patients Undergoing Percutaneous Coronary Intervention in Cardiogenic Shock or Cardiac Arrest: Insights From BMC2
Authors:
- Jacqueline M. VisinaJVJacqueline M. Visina
- Milan SethMSMilan Seth
- Eric P. CanteyECEric P. Cantey
- Elias J. DayoubEDElias J. Dayoub
- Brittany S. FullerBFBrittany S. Fuller
- Mir B. BasirMBMir B. Basir
- Thomas A. LalondeTLThomas A. Lalonde
- Theodore L. SchreiberTSTheodore L. Schreiber
- Timothy A. JosephTJTimothy A. Joseph
- Lindsey A. CiliaLCLindsey A. Cilia
- Hitinder S. GurmHGHitinder S. Gurm
- David E. HamiltonDHDavid E. Hamilton
Open Access
- 19 November 2026
- journal article
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
Abstract
No abstract availableFunding Information
- Blue Cross Blue Shield of Michigan Foundation
This publication has 26 references indexed in Scilit:
- Cangrelor During Percutaneous Coronary Intervention in Patients With Cardiogenic Shock or Cardiac ArrestJACC: Cardiovascular Interventions, 2025
- Healthcare Priorities: The “Young” and the “Old”Cambridge Quarterly of Healthcare Ethics, 2022
- Hemoglobin drop following postpartum hemorrhageScientific Reports, 2020
- Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarctionJournal of Thrombosis and Thrombolysis, 2020
- Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trialResuscitation, 2019
- Cangrelor Use in Cardiogenic ShockJACC: Cardiovascular Interventions, 2017
- Clopidogrel pharmacokinetics and pharmacodynamics in out-of-hospital cardiac arrest patients with acute coronary syndrome undergoing target temperature managementResuscitation, 2016
- High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrestResuscitation, 2014
- Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Prasugrel-Treated PatientsJACC: Cardiovascular Interventions, 2014
- Platelet Inhibition with Cangrelor in Patients Undergoing PCINew England Journal of Medicine, 2009